Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > TCRR TCR2 Therapeutics > Company Profile
TCRR TCR2 Therapeutics
1.140
-0.040-3.39%
Post Mkt Price
1.1400.0000.00%
Symbol
TCRR
Company Name
TCR2 Therapeutics
Listing Date
02/14/2019
Establishment Date
2015
CEO
Dr. Garry E. Menzel, PhD
Market
NASDAQ
Employees
137
Securities Type
DR
Fiscal Year Ends
12-31
Address
100 Binney Street,Suite 710
City
Cambridge
Province
Massachusetts
Country
United States of America
Zip code
02142
Phone
1-617-949-5200
Profile
TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA.
Company Overview
TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA.
CEO: Dr. Garry E. Menzel, PhD
Market: NASDAQ
Listing Date: 02/14/2019
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist